Progress in the study of treatment of age-related macular degeneration

International Journal of Ophthalmology

Volumn 6, Issue 6, 2006, Pages 1393-1396

  Tang, Yang ^a   Tang, Luo Sheng ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Age related macular degeneration; Treatment

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BENZOPORPHYRIN DERIVATIVE; CYCLOOXYGENASE 2; LUTETIUM TEXAPHYRIN; SQUALAMINE; TRIAMCINOLONE ACETONIDE; UROKINASE RECEPTOR; VASCULOTROPIN;

AGING; ARTICLE; CORNEA NEOVASCULARIZATION; DISEASE SEVERITY; HUMAN; LENS IMPLANTATION; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; RETINA SURGERY; RISK FACTOR;

EID: 33846056025     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Spandau UHM,Sauder G, Schubert U, Hammes HP, Jonas JB. Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo. Br J Ophthalmol, 2005;89(6):745-747
2. Duker JS MD. A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. Evidence-Based Eye Care, 2004;5(1):16-18
3. Gillies MC, Simpson JM, Luo WMPH, Penfold P, Hunyor AB, Chua W, Mitchell P, Billson F. A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration: One-Year Results. Arch Ophthalmol, 2003;121(5):667-673
4. Jonas JB, Akkoyun I, Budde W, Kreissig I, Degenring RF. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol, 2004;122(2):218-222
5. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology, 2003;110(8):1517-1525
6. Eyetech Study Group. Anti-vascular endothelial growth factor for subfoveal CNV secondary to age-related macular degeneration. Ophthalmology, 2003;110 (5): 979-986
7. Ciulla TA, Criswell MH, Danis RP, Williams JI, Mclane MP, Holroyd KJ. Squalamine Lactate Reduces Choroidal Neovascularization in a Laser-Injury Model in the Rat. Retina, 2003;23(6):808-814
8. Das A, Boyd NBS, Jones TR, Talarico NBS, McGuire PG. Inhibition of Choroidal Neovascularization by a Peptide Inhibitor of the Urokinase Plasminogen Activator and Receptor System in a Mouse Model. Arch Ophthalmol, 2004;122 (12): 1844-1849
9. Hu W, Criswell MH, Ottlecz A, Cornell TL, Danis RP, Lambrou GN, CiullaTA. Oral administration of lumiracoxib reduces choroidal neovascular membrane development in the rat laser-trauma model. Retina, 2005;25(8):1054-1064
10. Fujii GY, De JJ, Zarbin MA, Humayun MS, Au Eong KAH-GUAN, Phillips S. Unintentional transplantation of autologous retinal pigment epithelium during limited macular translocation. Retina, 2001;21(4):380-382
11. Van MJC, Ter AE, Hofland LJ, van Hagen PM, Mooy CM, Baarsma GS, Kuijpers RW, Boks T, Stalmans P. Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol, 2004;88(1):110-113
12. Sunness JS, Benner JD, Ziegler MD, Soltanian J. Limited macular translocation (MT) for atrophic macular disease. ARVO abstracts. Invest Ophthalmol Vis Sci, 2001;42(3):687
13. Toth CA, Freedman SF. MACULAR TRANSLOCATION WITH 360-DEGREE PERIPHERAL RETINECTOMY: Impact of Technique and Surgical Experience on Visual Outcomes. Retina, 2001;21(4):293-303
14. Eckardt C, Eckardt U. Macular translocatinn in nonexudative age-related macular degeneration. Retina, 2002;22(6):786-794
15. Abdel-Meguid A, Lappas, A, Hartmann, K, Auer, F, Schrage N, Thumann G, Kirchhof B. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol, 2003;87 (5):615-621
16. Cekic O, Ohji M, Keserci B, Sawa M, Zheng Y, Hayashi A, Ikuno Y, Nakata K, Gomi F, Tano Y. Evaluation of choroidal perfusion of the new central macular area by dilution analysis of indocyanine green angiography after macular translocation. Retina, 2004;24(2):210-214
17. Joseph DP, Uemura A, Thomas MA. Subretinal surgery for juxtafoveal choroidal neovascularization. Retina, 2003;23(4):463-468
18. Marcus DM, Sheils WC, Johnson MH, McIntosh SB, Leibach DB, Maguire A, Alexander J, Samy CN. External Beam Irradiation of Subfoveal Choroidal Neovascularization Complicating Age-Related Macular Degeneration: One-Year Results of a Prospective, Double-Masked, Randomized Clinical Trial. Arch Ophthalmol, 2001;119(2):171-180
19. Benson W. Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial. Evidence-Based Eye Care, 2002;3(4):206-207
20. Hart PM, Chakravarthy U, Chisholm IH, Bird AC, Stevenson MR, Owens SL, Hall V, Houston RF, McCulloch DW, Plowman N. Visual Outcomes in the Subfoveal Radiotherapy Study: A Randomized Controlled Trial of Teletherapy for Age-Related Macular Degeneration.Arch Ophthalmol, 2002;120(8):1029-1038
21. Finger PT, Gelman YP, Berson AM, Szechter A. Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study. Br J Ophthalmol, 2003;87(12):1497-1503
22. Marcus DM, Sheils WC, Young JO, McIntosh SB, Johnson MH, Alexander J, Samy CN. Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration. Br J Ophthalmol, 2004;88(1):114-119
23. Kim SY, Sadda S, Pearlman J, Humayun MS, de Juan EJr, Melia BM, Green W R. Morphometric analysis of the macular in eyes with disciform age-related macular degeneration. Retina, 2002;22(4):471-477
24. Park RI. The Bionic Eye: Retinal Prostheses. Int Ophthalmol Clin, 2004;44(4): 139-154
25. Werner L, Kaskaloglu, Apple DJ, Pandey SK, Macky TA, Izak AM, Trivedi RH, Heredia M, Morse SE. Aqueous Infiltration Into an Implantable Miniaturized Telescope. Ophthalmic Surg Lasers, 2002;33(4):343-348
26. Arden GB, Sidman RL, Arap W, Schlingemann, RO. Spare the rod and spoil the eye. Br J Ophthalmol, 2005;89(6):764-769
27. Blumenkranz MS. New Light on Drug Therapy for Choroidal Neovascularization. Retinal, 2002;22(4):518-524
28. Kim RW, Heier JS. Innovative Treatments for Exudative Age-Related Macular Degeneration. Int Ophthalmol Clin, 2004;44(4):41-50
29. Houle JM, Strong HA. Duration of skin photosen sitivity and incidence of photosensitivity reactions after administration of verteporfin. Retina, 2002;22 (6): 691-697
30. Rubin GS, Bressler NM, The treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Effects of vertepofin therapy on contrast sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Investigation-TAP Report No.4. Retina, 2002; 22(5):536-544
31. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) and Verteporfin in Photodynamic Therapy (VIP) Study Groups. Verteporfin therapy of subfoveal choroidal neovascularation in age-related macular degeneration: Meta-Analysis of 2-Year Safety Results in Three Randomized Clinical Trials: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Report No. 4. Retinal, 2004;24 (1):1-12
32. Vam Study Writing Committee. Verteporfin therapy in age-related macular degeneration (VAM): An Open-label Multicenter Photodynamic Therapy Study of 4, 435 Patients. Retina, 2004;24(4):512-520
33. Verteporfin In Photodynamic Therapy Study Group (VIP). Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol, 2001;131:541-560
34. Rougier MB, Franfcois L, Fourmaux E, Isber R, Colin J,Korobelnik JF. Complications and lack of benefit after transpopillary thermotherapy for occult choroidal neovascularization: 1-year results. Retina, 2005;25(6):784-788
35. Schnurrbusch UE, Welt K, Horn LC, Wiedemann P, Wolf S. Histological Findings of Surgically Excised Choroidal Neovascular Membranes After Photodynamic Therapy. Br J Ophthalmol, 2001;85(9):1086-1091
36. Zhou YD, Zhou TQ, Fan HJ. Transpupitlary thermotherapy of choroidal heovascularization in patients with age-related macular degeneration. Int J Ophthalmol(Guoji Yanke Zazhi), 2005;5(5):961-963
37. Zhang P, Wang YS, Hu D, Wu YL, Luo YJ, Han QH, Hui YN. Macular circulation changes and choroidal neovascularization in age-related macular degeneration. Int J Ophthalmol(Guoji Yanke Zazhi), 2003; 3(4):43-45
38. Newsom RSB, McAlister JC, Saeed M, McHugh, JDA. Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation. Br J Ophthalmol, 2001;85(2):173-178
39. Subramanian ML, Reichel E. Current indications of transpupillary thermotherapy for the treatment of posterior segment diseases. Curr Opin Ophthalmol, 2003; 14(3):155-158